# Who can license referral records? Decision tree | SourceX

Canonical: https://refer.sourcex.si/questions/who-can-license-appointment-referral-reconciliation-records
Last updated: 2026-11-04

Start with the administration director, who runs intake and scheduling and knows where the unmatched referrals went, then find who controls the records. In healthcare administration that is a legal question: if the company holds referrals as a business associate for practices, its contracts limit what it may do, and the practices may need to agree. The CEO of the controlling party authorizes a discussion; the privacy officer and counsel advise.

This decision tree belongs to the [appointment referral reconciliation guide](/guides/workflow-appointment-referral-reconciliation). It takes a partner from the first contact to the right introduction in a handful of questions and marks where the answer stays open until SourceX's rights review. This page is general information, not legal or compliance advice.

## The first contact and the final one

The administration or patient access director is the right first contact and usually the wrong final one. They know which referral requests, queue entries, tickets and closure confirmations exist, how many years each system holds and when legacy access ends. Running the scheduling platform is not authority to license what it holds.

In most healthcare settings two layers sit above the director. One is organizational: the CEO, who decides whether to explore licensing at all. The other is legal: whether the company is allowed to, given the agreements under which it holds patient information. A partner identifies both and introduces the executive, naming the director as the person who can explain the records.

## The decision tree

Answer the questions in order. Each answer sends you to the next question or adds a reviewer.

| Question | If yes | If no or not sure |
|---|---|---|
| 1. Is the company a provider that holds referrals about its own patients? | It is likely the covered entity; its own executive decides; go to 3 | Go to 2 |
| 2. Does it hold referrals on behalf of practices or a health system? | It is likely a business associate; the practices may hold the decision; go to 3 | Treat as unknown; counsel decides; go to 3 |
| 3. Is there a privacy officer? | They advise and often must sign off; go to 4 | Counsel takes that role; go to 4 |
| 4. Could the discussion be limited to operational data that is not patient information? | Note it as a possible narrower path; go to 5 | Go to 5 |
| 5. Is the CEO of the controlling party willing to take a call? | Introduce them, with the director named | Do not submit yet; ask who would decide |

Most management services, billing and central scheduling companies take the business associate branch at question 2. Most physician groups and health systems take the covered entity branch at question 1.

## Roles and what each can authorize

| Role | Why they matter | Can they authorize a data discussion? |
|---|---|---|
| Administration or patient access director | Owns intake and scheduling procedures, knows the exception queues | Rarely; the natural sponsor |
| Applications or IT lead | Knows systems, years, migration scope and access end dates | No |
| Privacy officer | Knows which records are protected health information and what agreements allow | Advises; often must sign off |
| General counsel | Reads business associate and practice agreements | Advises on whether the company holds the right |
| CEO of the controlling party | Decides whether to explore licensing | Yes, within what the contracts permit |
| Practice or health system leadership (business associate branch) | May control the underlying patient information | May need to agree |

Companies run by fractional executives still need the CEO to authorize; [whether a fractional CFO can sign for a company](/questions/can-fractional-cfo-sign-contracts-behalf-company) covers the fractional CFO's role.

## Where legal and privacy sign-off comes in

**Business associate limits.** HHS guidance says a business associate contract must establish the permitted and required uses and disclosures of protected health information by the business associate, and may not authorize a use the covered entity itself could not make. [What is a business associate](/questions/what-is-a-business-associate-hipaa) explains the role.

**Minimum necessary.** HHS also requires covered entities to make reasonable efforts to limit uses, disclosures and requests of protected health information to the minimum necessary for the purpose. That is one reason partners keep discovery at metadata level and never ask to see a referral.

**De-identification.** HHS recognizes two methods for meeting the Privacy Rule's de-identification standard: Expert Determination and Safe Harbor. The list of [18 HIPAA identifiers](/resources/18-hipaa-identifiers) shows what Safe Harbor removes. [Licensing healthcare operational data without PHI](/questions/license-healthcare-operational-data-without-phi) covers the narrower path from question 4. These decisions belong to the company and SourceX's review, never to the partner.

[Why data rights matter](/proof/why-data-rights-matter) sets out, in general terms, why a clean answer here comes before any buyer conversation.

## What stays unknown until SourceX's rights review

The tree identifies whom to introduce. It does not settle any of these:

- whether the company or its practices hold the right to license each record class
- whether patient information would need removing and which method could apply
- whether a narrower, non-patient operational dataset exists
- whether there is buyer interest, and on what terms

For SourceX, an introduced company needs 50+ full-time employees at peak (contractors excluded), a documented operating history, rights to license and an authorized contact. Companies in the U.S., Canada and the EU qualify, as do companies in the UK, Australia, New Zealand, India, Singapore, South Africa, Latin America, the UAE and Saudi Arabia when at least 70% of the data is in English. Partners sign the Channel Partner Agreement before submitting introductions. The [worked unmatched referral](/guides/appointment-referral-reconciliation-exception-examples) shows the kind of records involved, and the [referral brief template](/resources/appointment-referral-reconciliation-referral-brief-template) has a field for the controlling party.

## Next step

> **Refer a company. No cap on rewards.** Default reward on a company's first qualifying transaction: the greater of $50,000 plus 5% and 15% of Actual Supplier Payout, with no cap; further qualifying transactions first agreed within 12 months of the first Closing pay 15%. Eligibility and payment conditions apply, including the USD 100,000 Minimum Transaction, and a signed Schedule A or addendum can differ. A lead, meeting or signature alone does not trigger payment.

Once you know which party controls the referral records and that its CEO will agree to a discussion, [register as a partner](/register), check that company against [who qualifies](/who-qualifies) and read the [program terms](/terms) before you introduce the CEO.

## Sources

- https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/business-associates/index.html
- https://www.hhs.gov/hipaa/for-professionals/special-topics/de-identification/index.html
- https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/minimum-necessary-requirement/index.html
- https://refer.sourcex.si/terms
